Half-year report · HY
4323.TEDINET S100X1TJ
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥672m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥677m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥22.8bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥22.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥20.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥8.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.2bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.1bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥588m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥42m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥433m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥754m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥599m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥588m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥44.77 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.24 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 66.3% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥52m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥52m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥1.1bn |
| Global Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥984m |
| Global Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥942m |
| Global Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥42m |
| Global Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥220m |
| Medical Big Data Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| Medical Big Data Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥3m |
| Medical Big Data Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥194m |
| Package Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.3bn |
| Package Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.3bn |
| Package Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥14.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥48m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥48m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥977m |
| Global Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Global Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Global Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Global Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥51m |
| Medical Big Data Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Medical Big Data Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| Medical Big Data Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥104,000 |
| Medical Big Data Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥77m |
| Package Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Package Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Package Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1m |
| Package Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥641m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥48m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 552
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayments of lease obligations fin cf | Prior1InterimDuration | -19830000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -13751000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -6930000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -5550000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | － | JPY |
| Purchase of treasury stock fin cf | InterimDuration | -58887000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -558597000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -670316000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1InterimDuration | -2868000 | JPY |
| Dividends paid to non controlling interests fin cf | InterimDuration | -3380000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -588225000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -753907000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | 48815000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | -34919000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -384263000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 1982612000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 7515186000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 6742894000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 7130923000 | JPY |
| Cash and cash equivalents | InterimInstant | 8725507000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 897453000 | JPY |
| Salaries and allowances sga | InterimDuration | 957777000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 200688000 | JPY |
| Provision for bonuses sga | InterimDuration | 198714000 | JPY |
| Provision for directors bonuses sga | Prior1InterimDuration | 62957000 | JPY |
| Provision for directors bonuses sga | InterimDuration | 59720000 | JPY |
| Directors share based compensation expenses sga | Prior1InterimDuration | 5240000 | JPY |
| Directors share based compensation expenses sga | InterimDuration | 38200000 | JPY |
| Provision for directors retirement benefits sga | Prior1InterimDuration | 400000 | JPY |
| Provision for directors retirement benefits sga | InterimDuration | 600000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 28130000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 25378000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 137080000 | JPY |
| Research and development expenses sga | InterimDuration | 177858000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 8239108000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | 2567198000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1132858000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | 1321495000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 13260660000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 13260660000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 22210000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | 1361000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05236-000MedicalBigDataBusinessReportableSegmentMember | 104000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05236-000GlobalBusinessReportableSegmentMember | 23941000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 47616000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -47616000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05236-000DXAndSIBusinessMember | 8261318000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05236-000PackageBusinessReportableSegmentMember | 2568559000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |